Oxford-AstraZeneca s Covishield is being manufactured by the Pune-based Serum Institute of India.
New Delhi:
Amid multiple states reporting a shortage of COVID-19 vaccine, Serum Institute and Bharat Biotech have submitted to the Centre their production plan for the next four months, informing they can ramp it up to 10 crore and 7.8 crore doses respectively by August, official sources said on Wednesday.
The sources said the Union Health Ministry and the office of Drugs Controller General of India had sought from both the firms their production plan for June, July, August and September.
The Hyderabad-based Bharat Biotech s indigenously developed Covaxin and Oxford-AstraZeneca s Covishield, being manufactured by the Pune-based Serum Institute of India, are currently being used in India s inoculation drive against coronavirus.
Virtual Science Summit 2021 Creating Synergies with Scientific Diaspora in Australia
Virtual Science Summit 2021 Creating Synergies with Scientific Diaspora in Australia 03-May-2021 09:55:58
The Ministry of Foreign Affairs of Pakistan has established a multifaceted ‘Science Diplomacy Initiative’ that brings Pakistani Science & Technology stakeholders on the same platform with our scientific diaspora and innovative entrepreneurs.
In order to benefit from this initiative, the High Commission of Pakistan, Canberra, is planning to convene a Virtual Science Summit 2021 titled “Creating Synergies and Partnership with Scientific Diaspora in Australia”. The Summit seeks to engage our diaspora working in diverse scientific disciplines in Australia to create their synergies and partnership for:
Precisamos saber quem está com a verdade , diz governador do Piauí após reunião com Rússia sobre eficácia da Sputnik V globo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globo.com Daily Mail and Mail on Sunday newspapers.
CSIR-CMERI develops oxygen enrichment tech for treating Covid patients
By IANS |
6 Views
Major ports to waive-off charges for ships carrying oxygen-related cargo. Image Source: IANS News
New Delhi, April 26 : Amid the shortage of oxygen in hospitals across the country the CSIR-CMERI indigenously developed oxygen enrichment technology may be effective in treating COVID-19 patients.
Harish Hirani, Director, CSIR-CMERI, said that the organisation developed an oxygen enrichment unit requiring easily available oil free reciprocating compressor, oxygen grade zeolite sieves and pneumatic components.
This technology has tremendous potential. He urged all the participant industries/entrepreneurs to come forward at this crucial juncture and manufacture the device at the earliest.
CSIR-CMERI indigenously developed Oxygen enrichment technology may effective for treating COVID-19 patients: Dr V R Sirsath indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.